Last reviewed · How we verify

Vincristin — Competitive Intelligence Brief

Vincristin (Vincristin) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Oncology.

marketed Canalicular multispecific organic anion transporter 1, Multidrug resistance-associated protein 7, Multidrug resistance protein 1 Oncology Small molecule Live · refreshed every 30 min

Target snapshot

Vincristin (Vincristin) — Arbeitsgemeinschaft medikamentoese Tumortherapie.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Vincristin TARGET Vincristin Arbeitsgemeinschaft medikamentoese Tumortherapie marketed Canalicular multispecific organic anion transporter 1, Multidrug resistance-associated protein 7, Multidrug resistance protein 1
Anhydrovincaleukoblastine anhydrovinblastine Roswell Park Cancer Institute marketed Canalicular multispecific organic anion transporter 1, Multidrug resistance-associated protein 7, Multidrug resistance protein 1
Vinblastin Vinblastin The Lymphoma Academic Research Organisation marketed Canalicular multispecific organic anion transporter 1, Multidrug resistance-associated protein 7, Multidrug resistance protein 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Vincristin — Competitive Intelligence Brief. https://druglandscape.com/ci/vincristin. Accessed 2026-05-14.

Build your own brief

Pick any drug + add comparators: